Fig. 2From: Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patientsComparisons of glycemic and pleiotropic effects between SGLT2 inhibitors and DPP4 inhibitorsBack to article page